We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Informal Feedback Process Prior to Marketing Decisions
FDA Clarifies Informal Feedback Process Prior to Marketing Decisions
The FDA used a Q&A format to issue final guidance on an informal, non-binding process for sponsors to obtain preliminary feedback before submitting marketing applications.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor